TSHA NASDAQ
Taysha Gene Therapies, Inc.
1W: -0.9%
1M: -17.9%
3M: -27.4%
YTD: -11.8%
1Y: +45.6%
3Y: +55.9%
5Y: -76.9%
$4.63
-0.11 (-2.32%)
Weekly Expected Move ±5.9%
$4
$4
$5
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$5M
Revenue
-32.3% YoY
$-150M
Net Income
-61.4% YoY
$-136M
Free Cash Flow
-64.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-47.1%
ROA-37.2%
ROIC961.0%
Valuation
P/E-11.0
P/B4.4
EV/EBITDA-14.2
Leverage
Debt/Equity0.14
Current Ratio17.76
Interest Cov.-3572.7x
Quality Scores
Piotroski F3/9
Altman Z15.82
Beneish M0.00